Navigation Links
InVitria Sponsors ESACT 2009 in Dublin, Ireland
Date:6/5/2009

InVitria, a leading supplier of performance enhancing cell culture media supplements, to sponsor the 21st Meeting of the European Society for Animal Cell Technology (ESACT) in Dublin, Ireland from June 7-10, 2009.

Fort Collins, CO June 5, 2009 / b3c newswire / – The world-renowned ESACT ‘09 gathering will serve as host to scientific experts from academia and industry brought together to find “Cellular Solutions for Clinical Challenges.” As one of the sponsors, InVitria will be sharing with attendees the powerful effects of its portfolio of cell culture media supplements developed to solve the regulatory and performance challenges facing the life science industry.

InVitria recently introduced a new product called ZAP-CHO, a performance enhancing cell culture media supplement designed to improve cell growth and antibody production in mammalian cell culture.

“ZAP-CHO improves CHO product development in chemically defined media that are completely free of animal components,” said Steve Pettit, Ph.D., Director of Cell Culture Development with InVitria.  “Previously, the performance enhancements gained with ZAP-CHO was only possible by utilizing animal components such as FBS (fetal bovine serum or fetal calf serum) in cell culture media,” said Dr. Pettit.

Additionally, ZAP-CHO speeds-up cell line development and seed train expansion and also offers cost saving benefits by reducing operating costs as well as capital investment.
 
Recent publications, along with customer results has validated that another of InVitria’s leading cell culture supplements, Cellastim, a recombinant human serum albumin, outperforms other forms of albumin for growth and productivity. Cellastim is a key component in stem cell media and is used to safely optimize performance in CHO and hybridoma cell lines.

“ESACT is a tremendous venue to build awareness of InVitria’s product portfolio and collaborate with leaders in cellular biology,” said Scott Deeter, InVitria President and CEO. “InVitria’s products provide a unique opportunity for the cellular products industry to advance to a higher level of safety and productivity.”


About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.


Contact
Erik H. Vogel
InVitria
Marketing Manager
Phone: 1-800-916-8311
info@InVitria.com
www.InVitria.com


'/>"/>
b3c newswire

Related biology news :

1. InVitria to Unveil Powerful Cell Culture Media Component ZAP-CHO
2. InVitria Announces Launch of Recombinant Albumin for Diagnostics
3. Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center
4. WPI professor receives Fulbright Scholarship to work on tissue engineering in Ireland
5. Darwin anniversary heralds new conservation research era for Northern Ireland
6. Ireland Cancer Center researcher finds most triple-negative breast cancers express muc-1 target
7. For good or ill Ireland gains another mammal species
8. Ireland Cancer Center researchers advance stem cell gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
(Date:11/30/2016)... 30, 2016  Tempus, a technology company focused ... Penn,s Abramson Cancer Center have partnered to better ... to immunotherapy treatment based on next generation genomic ... of a research collaboration, Tempus will provide sequencing ... patient data to Penn. Utilizing next-generation sequencing, machine ...
(Date:11/30/2016)...   Merck , a leading science and technology ... set of agreements with Evotec AG, whereby Evotec AG ... reagents such as CRISPR and shRNA libraries. Combining access ... accelerated pathway to explore and identify new drug targets. ... new targets, a process that can be time- and ...
(Date:11/30/2016)... Triangle Park, North Carolina (PRWEB) , ... November 30, 2016 , ... ... (IUPAC) approved the names and symbols for four elements: nihonium (Nh), moscovium (Mc), ... Following a 5-month period of public review, the names earlier proposed by the discoverers ...
Breaking Biology Technology: